Chrysa Mineo's most recent trade in Cidara Therapeutics Inc was a trade of 19,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 19,000 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 3,320 | 0 (0%) | 0% | 221.5 | 735,380 | Common Stock |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 2,125 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 2,125 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 1,400 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 1,000 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 875 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 875 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 550 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 550 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 11,100 | 11,100 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Purchase of securities on an exchange or from another person at price $ 21.71 per share. | 02 Jun 2025 | 2,270 | 2,270 (0%) | 0% | 21.7 | 49,281 | Common Stock |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Purchase of securities on an exchange or from another person at price $ 23.44 per share. | 02 Jun 2025 | 1,050 | 3,320 (0%) | 0% | 23.4 | 24,614 | Common Stock |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 19,000 | 19,000 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 2,125 | 2,125 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 42,500 | 42,500 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 17,500 | 17,500 | - | - | Stock Option (right to buy) |